LV10275B - Derivative of tricyclic pyridone - Google Patents

Derivative of tricyclic pyridone Download PDF

Info

Publication number
LV10275B
LV10275B LVP-93-504A LV930504A LV10275B LV 10275 B LV10275 B LV 10275B LV 930504 A LV930504 A LV 930504A LV 10275 B LV10275 B LV 10275B
Authority
LV
Latvia
Prior art keywords
compound
formula
agent
oxo
chloro
Prior art date
Application number
LVP-93-504A
Other languages
English (en)
Latvian (lv)
Other versions
LV10275A (lv
Inventor
Richard Raimund Scherschlicht
Ulrich Widmer
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of LV10275A publication Critical patent/LV10275A/xx
Publication of LV10275B publication Critical patent/LV10275B/lv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D455/00Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • C07D455/06Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine containing benzo [a] quinolizine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/15Suppositories

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Anesthesiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyridine Compounds (AREA)
  • Electric Propulsion And Braking For Vehicles (AREA)
  • Plural Heterocyclic Compounds (AREA)
LVP-93-504A 1991-01-25 1993-06-08 Derivative of tricyclic pyridone LV10275B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH22891 1991-01-25

Publications (2)

Publication Number Publication Date
LV10275A LV10275A (lv) 1994-10-20
LV10275B true LV10275B (en) 1995-02-20

Family

ID=4182207

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-504A LV10275B (en) 1991-01-25 1993-06-08 Derivative of tricyclic pyridone

Country Status (30)

Country Link
US (2) US5281711A (fi)
EP (1) EP0496274B1 (fi)
JP (1) JPH0739415B2 (fi)
KR (1) KR920014811A (fi)
AT (1) ATE140002T1 (fi)
AU (1) AU649302B2 (fi)
BG (1) BG61057B2 (fi)
BR (1) BR9200217A (fi)
CA (1) CA2058640A1 (fi)
CZ (1) CZ280258B6 (fi)
DE (1) DE59206676D1 (fi)
DK (1) DK0496274T3 (fi)
ES (1) ES2089252T3 (fi)
FI (1) FI920268A (fi)
GR (1) GR3021126T3 (fi)
HU (2) HU207072B (fi)
IE (1) IE920225A1 (fi)
IL (1) IL100702A (fi)
IS (1) IS3804A (fi)
LT (1) LT3473B (fi)
LV (1) LV10275B (fi)
MX (1) MX9200242A (fi)
MY (1) MY108199A (fi)
NO (1) NO920338L (fi)
NZ (1) NZ241341A (fi)
RU (1) RU2073678C1 (fi)
SI (1) SI9210067A (fi)
UY (1) UY23362A1 (fi)
YU (1) YU48221B (fi)
ZA (1) ZA92361B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0650966A1 (de) * 1993-10-28 1995-05-03 F. Hoffmann-La Roche Ag Verfahren zur Herstellung eines Benzo(a)chinolizinon-Derivates
KR100295740B1 (ko) 1998-09-17 2001-11-05 박영구 N-치환된-하이드록시고리화알킬아민유도체의제조방법
US7277767B2 (en) 1999-12-10 2007-10-02 Srs Labs, Inc. System and method for enhanced streaming audio
US8445700B2 (en) 2008-11-24 2013-05-21 Council Of Scientific & Industrial Research Process for the preparation of optically active N-benzyl-3 hydroxypyrrolidines
US9258664B2 (en) 2013-05-23 2016-02-09 Comhear, Inc. Headphone audio enhancement system

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU191427B (en) * 1984-07-16 1987-02-27 Budapesti Mueszaki Egyetem,Hu Piezooptical effect reduced electrooptical light modulator
ZW17385A1 (en) * 1984-11-06 1986-02-19 Hoffmann La Roche Tricyclic pyridine derivatives
US4889848A (en) * 1984-11-06 1989-12-26 Hoffmann-La Roche Inc. Tricyclic pyridine derivatives
US4851418A (en) * 1987-08-21 1989-07-25 Warner-Lambert Company Naphthyridine antibacterial agents containing an α-amino acid in the side chain of the 7-substituent

Also Published As

Publication number Publication date
DK0496274T3 (da) 1996-09-23
KR920014811A (ko) 1992-08-25
JPH0739415B2 (ja) 1995-05-01
HUT60266A (en) 1992-08-28
EP0496274A1 (de) 1992-07-29
ES2089252T3 (es) 1996-10-01
HU9200128D0 (en) 1992-04-28
CZ280258B6 (cs) 1995-12-13
NO920338D0 (no) 1992-01-24
HU211259A9 (en) 1995-11-28
YU6792A (sh) 1994-11-15
LV10275A (lv) 1994-10-20
SI9210067A (en) 1995-02-28
BG61057B2 (bg) 1996-09-30
IS3804A (is) 1992-07-26
BR9200217A (pt) 1992-10-06
JPH04312585A (ja) 1992-11-04
IE920225A1 (en) 1992-07-29
IL100702A (en) 1995-08-31
HU207072B (en) 1993-03-01
YU48221B (sh) 1997-08-22
ZA92361B (en) 1992-09-30
LT3473B (en) 1995-10-25
NZ241341A (en) 1993-12-23
LTIP801A (en) 1995-02-27
EP0496274B1 (de) 1996-07-03
MY108199A (en) 1996-08-30
FI920268A0 (fi) 1992-01-22
ATE140002T1 (de) 1996-07-15
RU2073678C1 (ru) 1997-02-20
MX9200242A (es) 1992-07-01
AU1034092A (en) 1992-07-30
CS18292A3 (en) 1992-08-12
CA2058640A1 (en) 1992-07-26
IL100702A0 (en) 1992-09-06
NO920338L (no) 1992-07-27
US5326769A (en) 1994-07-05
UY23362A1 (es) 1992-07-21
GR3021126T3 (en) 1996-12-31
DE59206676D1 (de) 1996-08-08
AU649302B2 (en) 1994-05-19
FI920268A (fi) 1992-07-26
US5281711A (en) 1994-01-25

Similar Documents

Publication Publication Date Title
TW502012B (en) N-acylaminoalkylhydrazinecarboximidamides
DE69130651T2 (de) Verwendung von Prolaktin-Inhibitoren zur Einstellung des zirkadianen Prolaktin-Rhythmus
DE3750596T2 (de) 1,2,3,3a,8,8a-Hexahydro-1,3a,8-Trimethylpyrrolo[2,3-b]indole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel.
Yang et al. Elevated resting [Ca2+] i in myotubes expressing malignant hyperthermia RyR1 cDNAs is partially restored by modulation of passive calcium leak from the SR
Gangula et al. Sepiapterin reverses the changes in gastric nNOS dimerization and function in diabetic gastroparesis
Yoon et al. Intermittent fasting: a promising approach for preventing vascular dementia
KR20060065584A (ko) N-페닐-피페라진 유도체 및 5ht2c 수용체 관련 질환의예방 또는 치료 방법
CN103987386A (zh) 具有有相称效果的调节活性的(rs)-2-(2-氧代-4-苯基吡咯烷-1-基)乙酰胺化合物、药物物质(变体)及其应用、其组合物(变体)
DE69028605T2 (de) Aminocarbonylcarbamate verwandt mit Physostigmin, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE939630C (de) Verfahren zur Herstellung von heterocyclischen Verbindungen mit ringstaendiger Iminogruppe, die durch basische Gruppen substituiert ist
LV10275B (en) Derivative of tricyclic pyridone
DE69211892T2 (de) 1-(Pyrido[3,4-b]-1,4-oxazinyl-4-yl)-1H-Indole, Zwischenprodukte und ein Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
JP2006515618A (ja) 置換アルキルアミドピペリジン類
DE69933885T2 (de) Triphenylbutenderivate zur behandlung von neurologischen störungen
CA2169247A1 (en) Pharmaceutical compositions and method for the treatment of patients having fragile x syndrome and retarded maturities or affected by alzheimer's type diseases or huntington's chorea or who show similar symptoms of muscular hypotonie and similar s ates
NO322359B1 (no) 1-(syklisk amino)-alkylsykloheksanforbindelser, farmasoytiske preparater derav og deres anvendelse som antikonvulsive midler
JP5301474B2 (ja) 4−[2−(4−メチルフェニルスルファニル)フェニル]ピペリジン塩の液体製剤
EP0048132B1 (en) The use of dihydro-1h-pyrrolizine-3,5(2h,6h)-dione as a cognition activator, pharmaceutical compositions containing that compound, and the production of such compositions
NO127670B (fi)
JPH0374359A (ja) 4―(n―置換アミノ)―2―ブチニル―1―尿素およびチオ尿素ならびにそれらの誘導体
CN106748969B (zh) 一种n-(4-苄基哌啶基)-阿魏酰胺化合物、制备方法及其用途
US20230241150A1 (en) Compositions and Uses Thereof
NO762352L (fi)
EP1753757B1 (de) Substituierte 2,5-diaminomethyl-1h-pyrrole
EP1751101A1 (de) Substituierte 5-aminomethyl-1h-pyrrol-2-carbonsäureamide